BioSpace News Archive

Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of potent novel monotherapeutics, announced today that the studies performed on the Company’s patented compound, Atopidine™, suggest that Atopidine™ has outperformed cannabidiol (CBD) in preventing inflammatory responses relevant to UVB-radiation in one of its studies.

OralDNA ® Labs announces the availability of a PCR test for the novel coronavirus (SARS-CoV-2) under their OraRisk ® line of salivary diagnostics. FDA has been notified of validation and an Emergency Use Authorization will be filed within 15 days as required by FDA guidance. As a CLIA-certified and CAP accredited high-compl

Global health service company Cigna Corporation will release its first quarter 2020 financial results on Thursday, April 30, 2020 and will host a conference call on the same day.

Interlink Electronics, Inc. (OTC: LINK), a trusted global provider of human-machine interface (HMI) sensors and IoT solutions, today announced that it has quadrupled its output of components used in the making of lifesaving equipment in support of the relief effort against the COVID-19 pandemic.

Medtec China 2020 will be held from September 14–16 at SWEECC Halls 2&4 this year, “MDiT Forum and Regulation Summit 2020" is also going to return, continuing to focus on “regulations, quality and technology,” joining hands with medical device industry authorities and experts, to bring a unique industry education opportunity.

With an aim of raising $20 million, and initial commitment of over $7 million, new rapid response fund advances direct cash support and policy responses for and with working families affected by COVID-19

Biocept, Inc. , today announced that on April 14, 2020 it entered into a securities purchase agreement with several institutional investors

AIkido Pharma Incorporated (Nasdaq: AIKI) today announced that it has secured an exclusive world-wide license for a broad spectrum antiviral drug platform. The licensed technology is a broadly acting pan-viral inhibitory compound with efficacy against multiple viral pathogens. The technology works to inhibit replication of multiple viruse

Macromoltek, Inc. today announced the application of its computational design technology for their recently disclosed partnership with Cytovia Therapeutics for the potential treatment of SARS-CoV-2. To urgently address the growing impacts of the COVID-19 pandemic, Macromoltek is partnering with Cytovia Therapeutics

XBiotech Inc. (NASDAQ: XBIT) announced today that a novel antibody it has discovered that neutralizes interleukin-1 alpha (IL-1⍺) has now been advanced as a product candidate for clinical and commercial development. XBiotech discovered the IgG1 monoclonal antibody from a healthy donor with natural immunity against IL-1⍺. Creating medicines from natural human immunity is the hallmark of XBiotech’s approach to developing a new generation of break